Amid the resurgence in Covid cases, China's indigenous vaccines, "CanSino" and "BBIBPCorV," were heavily scrutinized based on their efficacy rates. There were concerns about the legitimacy of these vaccines raised concerns after certain documents were leaked online, labeled "extra urgent and
Turkish government which initially accepted Chinese vaccines is now scrutinising its efficacy after learning of China's involvement in data tempering of side effects only to enhance its vaccine sale.
Expressing concern over the spurt in Covid-19 cases in China, former Indian diplomat KP Fabian on Tuesday said, "over 60 per cent of China and 10 per cent of the world population is likely to be infected with Covid and millions may die."
Repeated explosive outbreaks of Covid in China along with tested and proven lack of effectiveness of its vaccines, has created a problem for its own citizens and people around the world, The Singapore Post, a news outlet with an online portfolio reported.
Beijing [China], July 26 (ANI): Chinese netizens questioned why the Chinese federal and state leaders took the domestically produced vaccines too late and raised doubts about the efficacy of the same, media reports said.
Beijing [China], June 25 (ANI): Things have become murky in China as coronavirus cases are flaring up. China- manufactured vaccines have turned out ineffective, making already-vaccinated people prone to new infections.
New Delhi [India], March 2 (ANI): Since the Covid-19 pandemic, China has been trying to portray itself as a reliable partner for economic recovery. But just like the Chinese vaccines which have raised questions about efficacy, the country's partnership in economic recovery comes with waste,
Hanoi [Vietnam], November 26 (ANI): Another worker in the Vietnamese city Thanh Hoa has died after receiving a Vero Cell COVID-19 vaccine shot, local media reported adding that two others had also passed away due to the vaccination.
Islamabad [Pakistan], November 11 (ANI): Pakistan on Thursday approved Chinese COVID-19 vaccines Sinopharm and Sinovac for children above 12 with an efficacy rate of 79 per cent and 51 per cent respectively.
Beijing [China] October 4 (ANI): Countries that once relied on COVID-19 vaccines from Beijing have now turned up to jabs from the Western countries amid the growing concerns about Chinese vaccines' efficiency against the Delta variant of SARS-CoV-2.